NCT01278940View on ClinicalTrials.gov

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

December 31, 2015

Conditions
Malignant Melanoma
Interventions
BIOLOGICAL

Dendritic Cells (DC) malignant melanoma

The patients were assigned to intradermal or intranodal DC vaccination

PROCEDURE

IL-2

IL-2 were administrated by intranodal injection

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT01278940 - Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma | Biotech Hunter | Biotech Hunter